Jan Tavernier

BioTrove, Inc. develops, manufactures and markets systems, consisting of laboratory instruments and related consumables, for genomic analysis, high-throughput screening and molecular diagnostics. The company was founded by Tanya S. Kanigan and Colin J. H. Brenan in 2000 and is headquartered in Woburn, MA.

FORMA Therapeutics, Inc. discovers and develops medicines for cancer and other genetically driven diseases. Its drug discovery engine deploys screening and structure-based approaches across broad families of targets involved in tumor metabolism, epigenetics, protein homeostasis, and protein-protein interactions. The company was founded by Steven Tregay, Nikolai Kley, Stuart L. Schreiber, Todd R. Golub, Michael Foley and Alexis Borisy in 2008 and is headquartered in Watertown, MA.

Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC.

The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA.

The Brigham & Women's Hospital, Inc. provides health care services. The firm offers treatment for cancer, cardio vascular, neurosciences, orthopedic, arthritis, women's health and clinical services. The company was founded in 1980 and is headquartered in Boston, MA.

Aesgen, Inc. develops pharmaceutical products resulting from cancer research collaborations, and specialized delivery of peptides, proteins, and small molecules for critical care. The company is headquartered in Princeton, NJ.

Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA.

MyCartis NV develops technologies for healthcare personalization needs. It offers Evalution, a multiplex analysis platform to develop protein and nucleic-acid based clinical biomarkers. The company provides disruptive solutions in the fields of clinical and translational research for various applications in the detection of proteins and nucleic acids, such as sandwich immunoassays, antibody assays, genotyping assays, and mutation analysis assays to customers and partners. It offers products for various disease areas, including cell signalling, cardiovascular, oncology, and preeclampsia. The company was founded by Koen Kas in August 2004 and is headquartered in Ghent, Belgium.

Excel Medical Ventures LLC (Excel Medical Ventures) is a venture capital firm founded in 2004 by Steven R. Gullans. The firm is headquartered in Boston, Massachusetts.

RxGen, Inc. operates as a translational research company. It specializes in the fields of ophthalmology, central nervous system, cardiovascular and metabolic related disease and disorders, and have advanced discovery and development. The company was founded by Christopher M. Stanley, Steven R. Gullans and Harry H. Penner, Jr. and is headquartered in Manhattan Beach, CA.

HealthCare.com, Inc. operates and maintains health information online portals. The firm specializes in health insurance, healthcare data, medicare and online advertising. It offers advertising solutions for agents, brokers and insurance companies. The company was founded by Jeffrey C. Smedsrud, Howard Yeh, Julio Gonzalez Arrivillaga, Jose Vargas, Keith Cox and Matias de Tezanos in October 2007 and is headquartered in Miami, FL.

Cleveland HeartLab, Inc. operates as a holding and clinical reference laboratory company. It focuses on novel molecular biomarker technologies and the creation of proprietary diagnostic tests. The company was founded by Jake Orville and Marc S. Penn in 2009 and is headquartered in Cleveland, OH.

BIOCIUS Life Sciences, Inc. provides medical laboratory services. The company was founded in 2009 and is headquartered in Wakefield, MA.

N-of-One, Inc. engages in the provision of clinical evidence to translate molecular test results into therapeutic options. It offers clinical interpretation, precision insights and clinical trial match solutions. It serves to commercial laboratories, hospital laboratories and medicine programs. The company was founded by Jennifer Levin Carter in 2008 and is headquartered in Lexington, MA.

CookUnity, Inc. provides meals delivery services. It offers well-balanced and nutritious meals. The company was founded by Matias Serebrinsky, Lucia Cisilotto, and Mateo Marietti in 2014 and is headquartered in Brooklyn, NY.

CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA.

Kaptyn, Inc. engages in the design and development of transportations-as-a-Service (TaaS) technology. Its taxi platform connects fleets, drivers, and regulators to a marketplace of taxi solutions industry. The company was founded by Andrew Meyers and Sergio Fernandez de Cordova in 2017 and is headquartered in Las Vegas, NV.

Peoplefund, Inc (Peoplefund Inc) is a private equity/venture capital firm founded in 2006 by Matias de Tezanos and Diego Fernandez. The firm is headquartered in Miami, Florida.

Aelin Therapeutics NV develops drugs for antibiotics and first-in-class therapeutics. The company is based in Leuven, Belgium. The Belgian company was founded in 2017. The CEO is Els Beirnaert.

Alexis Bio LLC operates as a clinical-stage biotechnology company. It develops a platform focused on immunogenomic reprogramming of live foreign cells from other species for the purpose of transplanting tissues and organs into human patients. The company was founded by Paul Holzer and Jon Adkins in 2019 and is headquartered in Enfield, NH.

OS Therapies, Inc. operates as a clinical stage biopharmaceutical company. It engages in identification, development, and commercialization of treatments for Osteosarcoma and other related diseases. The company was founded by Paul A. Romness on April 12, 2018 and is headquartered in Rockville, MD.

Montis Biosciences BV engages in the development of immune-oncology therapeutics targetting the intersection between vascular dysfunction and immune suppression to treat solid tumors. It offers target screening and assay platform to discover novel targets modulating interactions between tumor endothelial cells and perivascular macrophages. The company was founded by Peter Carmeliet and Massimiliano Mazzone and is headquartered in Meise, Belgium.

Flamingo Therapeutics BV is a Belgian company that specializes in developing RNA-targeted therapies for oncology. The company is based in Leuven, Belgium and was founded by Mike Garrett and Floor Stam. Flamingo is dedicated to delivering therapeutic benefit to patients living with cancer and believes that their programs and approach can successfully address large unmet medical needs where RNA-targeting can be effective. The company's clinical-stage pipeline focuses on targeting undruggable transcription factors and splice variants. The CEO is Stephane van Rooijen.

Navigation Sciences, Inc. is a private company that specializes in developing the NaviSci™ system, which provides real-time margin measurement for precision cancer surgery. The company is based in Brookline, MA. The system is designed to address the growing need to locate and remove lung and other soft tissue cancers. The company was founded in 2017 by Jayender Jagadeesan, Alan D. Lucas, and Raphael Bueno. Alan D. Lucas has been the CEO since 2017.

Part of Orionis Biosciences, Inc., Orionis Biosciences BV operates as a drug discovery and Belgian development biotechnology company. The company is based in Ghent, Belgium. The company was founded in 2015. Nikolai Kley has been the CEO of the company since 2015.

Metis Minds, Inc. is a company that offers a digital curriculum called Skylar's Run, which is a video game designed to enhance children's cognitive abilities, including attention, impulse control, and self-regulation. The company is based in Orlando, FL. The game measures and adapts to the child's attention levels, offering a personalized level of challenge. The company was founded by Steven R. Gullans and Barry K. Herman, and Steven R. Gullans has been the CEO since incorporation.